India to Philippines: Syringe Export Trade Route
India has recorded 97 verified shipments of Syringe exported to Philippines, representing a combined trade value of $11.2M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $115.8K USD. The leading Indian exporter is INDIAN IMMUNOLOGICALS LIMITED, which accounts for 74% of total export value with 24 shipments worth $8.3M USD. On the buying side, 2 WORLD TRADERS INC is the largest importer in Philippines with $8.8M USD in purchases. The top 3 suppliers — INDIAN IMMUNOLOGICALS LIMITED, BRAWN LABORATORIES LIMITED, INDIAN IMMUNOLOGICALS LTD — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Syringe corridor is one of India's established pharmaceutical export routes, with 97 shipments documented worth a combined $11.2M USD. The route is dominated by INDIAN IMMUNOLOGICALS LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $115.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with syringe's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 26.2%, placing it at rank #16 among India's top syringe export destinations globally.
On the import side, key buyers of Indian syringe in Philippines include 2 WORLD TRADERS INC, AMBICA INTERNATIONAL CORPORATION, 2MG 2MG INC and 20 others. 2 WORLD TRADERS INC is the single largest importer with 24 shipments valued at $8.8M USD.
Route Characteristics
- Average transit25 days
